ABT EV/EBITDA: current value, 10-year range and year-by-year history
Cash & Leverage
ABT's ev/ebitda is higher than 65% of the last 10 years.
EV/EBITDA History
ABT EV/EBITDA by year
Yearly range of ABT’s ev/ebitda from 2016 to 2026. Over the full period it ranged from 13.2 to 28.6, averaging 20.4.
| Year | Low | Average | High | Year-end |
|---|---|---|---|---|
| 2026 | 15.3 | 18.2 | 23.2 | 21.8 |
| 2025 | 18.4 | 20.5 | 23.3 | 19.4 |
| 2024 | 17.6 | 19.3 | 20.8 | 18.9 |
| 2023 | 15.0 | 18.0 | 20.9 | 20.0 |
| 2022 | 13.2 | 16.1 | 21.2 | 15.5 |
| 2021 | 17.6 | 21.6 | 26.9 | 21.4 |
| 2020 | 16.1 | 23.9 | 28.6 | 23.2 |
| 2019 | 19.4 | 21.9 | 23.7 | 21.5 |
| 2018 | 19.1 | 21.0 | 22.9 | 20.9 |
| 2017 | 19.1 | 22.3 | 25.5 | 20.2 |
| 2016 | 16.8 | 20.5 | 23.1 | 20.6 |
Get notified when ABT EV/EBITDA crosses a threshold
Free — one alert setup, notifications by push, Telegram, or Discord.
An acquisition-style valuation multiple: Enterprise Value (market cap + net debt) divided by operating earnings before accounting adjustments. Compares companies fairly regardless of their capital structure.
(Market Cap + Net Debt) / EBITDAUnlike P/E, this metric accounts for debt — two companies with identical operations but different leverage will show similar EV/EBITDA. Low vs history suggests the total business is modestly priced.
- EBITDA ignores capital expenditure. For asset-heavy businesses (airlines, mining, utilities), this understates the real cost — use EV/EBIT or EV/FCF instead.
- Large acquisitions temporarily spike net debt and can distort the ratio for 1–2 years during integration.
Is ABT EV/EBITDA High or Low Right Now?
Abbott Laboratories's EV/EBITDA is currently 21.8, which is above average relative to its 10-year historical range. The 10-year median EV/EBITDA for ABT is approximately 20.4. See all ABT valuation metrics →
Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.